Wegovy Launches in China
Danish pharmaceutical company Novo Nordisk has launched its popular weight-loss drug Wegovy in China, a market with over 180 million people living with obesity. The launch follows regulatory approval granted in June, targeting patients paying out-of-pocket as the drug will not be covered by China’s national healthcare insurance. Novo’s move intensifies competition with Eli Lilly, […]
Continue Reading